Moderna gets full US approval for COVID injection in children
July 10 (Reuters) – The U.S. Food and Drug Administration has granted full approval for Moderna’s (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday. The shot was previously available for pediatric populations under emergency […]
Read More
